在印度人口中,糖尿病前期妇女的新型数据驱动的病理生理现象
Elezebeth Mathews1, Anjaly Joseph1, Thakarakattil Narayanan Nair Anand2
1Department of Public Health and Community Medicine, Central University of Kerala, Kasaragod, India.
Diabetes research and clinical practice
|July 16, 2025
概括
在印度成年人中发现了四种不同的糖尿病前表型. 综合胰岛素抵抗性和缺陷前糖尿病 (CIRDP) 和高血压中度胰岛素缺陷前糖尿病 (HBPMIDP) 显示糖尿病的进展较高. 贝塔细胞功能障碍是常见的.
科学领域:
- 内分泌学 在内分泌学.
- 代谢综合征是代谢综合征的一种.
- 公共卫生 公共卫生
背景情况:
- 糖尿病前期是2型糖尿病的重要危险因素.
- 关于印度人群中糖尿病前期病理生理现象的数据有限.
- 了解这些表型对于有针对性的干预至关重要.
研究的目的:
- 在印度队列中识别数据驱动的糖尿病前期病理生理现象.
- 调查这些表型与糖尿病发病率之间的关联.
- 为了评估糖尿病前期表型到糖尿病的一年进展.
主要方法:
- 针对1455名糖尿病前期患者的调查样本进行了表征.
- 基因基因聚类被用来根据血糖,脂肪,脂质不良,β细胞功能,胰岛素耐药性和血压来识别表型.
- 后勤回归分析评估了一年多的糖尿病发病率风险.
主要成果:
- 确定了四种不同的糖尿病前表型:CIRDP (22.2%),SIROP (19.9%),SIDP (37.4%) 和HBPMIDP (20.5%).
- 与SIDP相比,在CIRDP (OR:6.07) 和HBPMIDP (OR:2.05) 中观察到糖尿病的一年进展率最高.
- 80%的已识别的糖尿病前期表型表现出β细胞功能障碍.
结论:
- 前糖尿病表型CIRDP和HBPMIDP与一年内发展为糖尿病的风险较高有关.
- 贝塔细胞功能障碍是大多数已识别的糖尿病前表型中普遍存在的特征.
- 这些发现凸显了糖尿病前期的多样性和印度人群个性化风险评估的需要.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes: Symptoms, Diagnosis, and Complications
697
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
697
Diabetes: Management and Pharmacotherapy
402
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
402
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
37
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
37


